MX356408B - Metodo para obtener proteinas recombinantes con capacidad inmunogenica en pichia pastoris y su uso en una preparacion de vacunas contra virus de influenza. - Google Patents
Metodo para obtener proteinas recombinantes con capacidad inmunogenica en pichia pastoris y su uso en una preparacion de vacunas contra virus de influenza.Info
- Publication number
- MX356408B MX356408B MX2011013020A MX2011013020A MX356408B MX 356408 B MX356408 B MX 356408B MX 2011013020 A MX2011013020 A MX 2011013020A MX 2011013020 A MX2011013020 A MX 2011013020A MX 356408 B MX356408 B MX 356408B
- Authority
- MX
- Mexico
- Prior art keywords
- pichia pastoris
- recombinant
- influenza virus
- ah1n1
- vaccines against
- Prior art date
Links
- 241000235058 Komagataella pastoris Species 0.000 title abstract 6
- 241000712461 unidentified influenza virus Species 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 title abstract 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 title abstract 2
- 230000002163 immunogen Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 230000003612 virological effect Effects 0.000 abstract 3
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 206010022000 influenza Diseases 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 239000013598 vector Substances 0.000 abstract 2
- 229910052798 chalcogen Inorganic materials 0.000 abstract 1
- 150000001787 chalcogens Chemical class 0.000 abstract 1
- 238000010353 genetic engineering Methods 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
La presente invención se refiere al campo de la ingeniería genética y biotecnología y en particular en la producción de vacunas contra el virus de influenza AH1N1, y se refiere a un método para obtener proteínas recombinantes con capacidad inmunogenica en Pichia pastoris y su uso en una preparación de vacunas contra virus de influenza, dicho método comprende las fases de: Obtener mediante ingeniería molecular una primer y segunda secuencia de ADN recombinante que le confiera a Pichia pastoris la capacidad de producir antígenos virales de Influenza AH1N1 MX 2009; Integrar cada secuencia de ADN recombinante de los vectores pPIC9:HASTA30762 y pPIC9:HA30780 obtenidos en la fase I, al genoma de Pichia pastoris, para obtener una primer y segunda capa de Pichia pastoris recombinante con capacidad de producción de un Antígeno viral por cada vector, contra AH1NI México 2009; Producir un primer y segundo antígenos virales recombinantes de Influenza AH1N1 México 2009 en la Pichia pastoris recombinante obtenida en fase II.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2011013020A MX356408B (es) | 2011-12-05 | 2011-12-05 | Metodo para obtener proteinas recombinantes con capacidad inmunogenica en pichia pastoris y su uso en una preparacion de vacunas contra virus de influenza. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2011013020A MX356408B (es) | 2011-12-05 | 2011-12-05 | Metodo para obtener proteinas recombinantes con capacidad inmunogenica en pichia pastoris y su uso en una preparacion de vacunas contra virus de influenza. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2011013020A MX2011013020A (es) | 2013-06-18 |
| MX356408B true MX356408B (es) | 2018-03-08 |
Family
ID=49125614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2011013020A MX356408B (es) | 2011-12-05 | 2011-12-05 | Metodo para obtener proteinas recombinantes con capacidad inmunogenica en pichia pastoris y su uso en una preparacion de vacunas contra virus de influenza. |
Country Status (1)
| Country | Link |
|---|---|
| MX (1) | MX356408B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110325208A (zh) | 2016-09-16 | 2019-10-11 | 威克斯技术公司 | 针对流感的疫苗接种的组合物和方法 |
-
2011
- 2011-12-05 MX MX2011013020A patent/MX356408B/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| MX2011013020A (es) | 2013-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2012106377A3 (en) | Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof | |
| EP3199545A3 (en) | Computationally optimized broadly reactive antigens for h1n1 influenza | |
| WO2013044203A3 (en) | Novel influenza hemagglutinin protein-based vaccines | |
| MY166953A (en) | Computationally optimized broadly reactive antigens for h5n1 and h1n1 influenza viruses | |
| EA201590304A1 (ru) | Вакцина рекомбинантного модифицированного вируса осповакцины анкара респираторно-синцитиального вируса | |
| EA201201025A1 (ru) | Молекулы нуклеиновых кислот гриппа и вакцины, изготовленные из них | |
| CA2863981A1 (en) | Computationally optimized broadly reactive antigens for h3n2, h2n2, and b influenza viruses | |
| IL236650B (en) | Immunogenic combination, nucleic acids or vectors encoding it, host cells or compositions comprising them, and therapeutic uses thereof, process of producing an infectious virus and method for recombinant production of the mycobacterial antigens | |
| EA201591287A1 (ru) | Вакцины, содержащие стабилизированные тримеры оболочки вируса иммунодефицита человека, и способы их применения | |
| EA201892795A1 (ru) | Молекула нуклеиновой кислоты, кодирующая коровый белок вируса гепатита в, и вакцина, содержащая указанную молекулу | |
| MX2014004214A (es) | Moleculas de acido ribonucleico policistronicas auto-replicantes recombinantes. | |
| SG10201901735XA (en) | Recombinant modified vaccinia virus ankara (mva) filovirus vaccine | |
| MY180109A (en) | Computationally optimized broadly reactive antigens for human and avian h5n1 influenza | |
| JP2016520530A5 (es) | ||
| WO2013178627A3 (en) | Protein assembler | |
| HK1207871A1 (en) | Peptides derived from viral proteins for use as immunogens and dosage reactants | |
| ZA202100386B (en) | Influenza virus hemagglutinin mutants | |
| MX363149B (es) | Vacunas de nucleoproteina de la influenza. | |
| AU2013352179A8 (en) | Computationally optimized broadly reactive antigens for H1N1 influenza | |
| CO6670515A2 (es) | Vectores de parapoxvirus | |
| MX356408B (es) | Metodo para obtener proteinas recombinantes con capacidad inmunogenica en pichia pastoris y su uso en una preparacion de vacunas contra virus de influenza. | |
| WO2012040266A3 (en) | Gene-based adjuvants and compositions thereof to increase antibody production in response to gene-based vaccines | |
| WO2008118936A3 (en) | Method of elicting immune response with a modified mva viral hiv-1 vector | |
| Rong et al. | Chemistry and materials development of protein-based nanoparticles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| GD | Licence granted |